Get started
Author

RL Ohsfeldt

Observed names: R L Ohsfeldt, R Ohsfeldt, R.L. Ohsfeldt
OpenAlex ID: A5072093206
Medicaid payment rates for nursing homes, 1979-86.
1990 · S F Gohmann, R L Ohsfeldt · PubMed Central · 4
Medical care costs associated with postmenopausal hormone replacement therapy
1999 · Jeremy W. Bray, JM Thorp, et al. · 2
OP0254 A propensity score-matched (PSM) analysis of organ damage in patients with systemic lupus erythematosus (SLE) from the pooled bliss long-term extension (LTE) trials versus the toronto lupus cohort (TLC)
2018 · M. Urowitz, R.L. Ohsfeldt, et al. · Annals of the Rheumatic Diseases · 1
PDF
Pos5 Economic Evaluation of Short-term Non-vertebral Fracture-related Costs Among Osteoporosis Treatments
2004 · RL Ohsfeldt, NN Borisov, et al. · Value in Health · 1
PDF
Pwm6: Impact of Postmenopausal Hormone Replacement Therapy on Resource Utilization Associated With Adverse Events
1999 · AJ Chawla, ST Kennedy, et al. · Value in Health · 1
PDF
EPH125 Geographic Disparities in Chronic Kidney Disease Hospitalizations: Exploring Associations with Neighborhood Socioeconomic Status in Texas
2024 · L Zhong, R Farej, et al. · Value in Health
PDF
Pcn251 Estimating Quality-adjusted Life Years (qalys) Through Quality-adjusted Time Without Symptoms or Toxicity (qtwist) in Rcts: an Alternative to Economic Modelling
2019 · A. Briggs, M. Marian, et al. · Value in Health
Rapid Estimation of Smoking-Attributable Mortality and Economic Costs
2018 · A Lorden, LA Beebe, et al. · Value in Health
FRI0298 Application of propensity score-matching methods to compare data from long-term extension trials with data from an existing lupus registry
2017 · MB Urowitz, R Wielage, et al. · Annals of the Rheumatic Diseases
PDF
Pcv84 Cost-effectiveness of Rosuvastatin 10 Mg in the Reduction of Cardiovascular Morbidity and Mortality in Patients at Risk of Cardiovascular Disease
2010 · R Ohsfeldt, SK Gandhi, et al. · Value in Health
PDF
Pcv70 Cost-effectiveness of Rosuvastatin 20 Mg in Secondaryprevention Patients in the United States
2010 · R Ohsfeldt, SK Gandhi, et al. · Value in Health
PDF
The cost-effectiveness of rosuvastatin 20 mg for the prevention of cardiovascular morbidity and mortality - a swedish economic evaluation of the JUPITER trial in EUROPEAN HEART JOURNAL, vol 31, issue , pp 225-225
2010 · RL Ohsfeldt, Anders Olsson, et al.
Pcv64 Economic Burden of Atherosclerosis Among Patients With Type-2 Diabetes Mellitus
2009 · RL Ohsfeldt, SK Gandhi, et al. · Value in Health
Prs18 Differences in Treatment Costs and Resource Utilization Among Copd Patients Treated With Albuterol Mdi or Levalbuterol Mdi
2008 · R Ohsfeldt, KH Summers, et al. · Value in Health
PDF
Pcv30 Cost-effectiveness Among Brand and Generic Statins Based on Real-world Effectiveness: Implications for Statin Formulary Design
2007 · RL Ohsfeldt, SK Gandhi, et al. · Value in Health
Pcv16 Rosuvastatin Is More Cost-effective Compared to Atorvastatin and Simvastatin for Hyperlipidemia Management in High-risk Patients in Routine Clinical Practice
2006 · RL Ohsfeldt, SK Gandhi, et al. · Value in Health
Pcv5 Potential Cost Savings From Acute Coronary Syndrome Treatment Improvements
2005 · RW Klein, RL Ohsfeldt, et al. · Value in Health
Pih23 Health Preferences and Willingness to Payto Reduce Exposure to Post-menopausal Risk Factors
2005 · SL Szeinbach, SE Harpe, et al. · Value in Health
PDF
Pcv28 an Arb Cost-effectiveness Model in Treating Mild-to-moderate Hypertension
2004 · HJ Smolen, RW Klein, et al. · Value in Health
PDF
Prk9: Cost-effectiveness of Tamsulosin, Doxazosin and Terazosin in the Treatment of Benign Prostatic Hyperplasia
2003 · RL Ohsfeldt, KJ Kreder, et al. · Value in Health
Modeling the Annual Cost of Postmenopausal Prevention Therapy Using Hormone Replacement Therapy, Raloxifene, and Alendronate
1999 · C D Mullins, R L Ohsfeldt · Menopause The Journal of The North American Menopause Society
Works count: 21
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type